nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamsulosin—prostate cancer—Betamethasone—hematologic cancer	0.258	0.5	CpDpCtD
Tamsulosin—prostate cancer—Dexamethasone—hematologic cancer	0.258	0.5	CpDpCtD
Tamsulosin—ORM1—Imatinib—hematologic cancer	0.0382	0.147	CbGbCtD
Tamsulosin—CYP2D6—Lomustine—hematologic cancer	0.0164	0.063	CbGbCtD
Tamsulosin—CYP2D6—Idarubicin—hematologic cancer	0.0146	0.0561	CbGbCtD
Tamsulosin—CYP2D6—Hydroxyurea—hematologic cancer	0.0124	0.0477	CbGbCtD
Tamsulosin—CYP3A4—Bexarotene—hematologic cancer	0.0112	0.0431	CbGbCtD
Tamsulosin—CYP2D6—Bortezomib—hematologic cancer	0.0108	0.0415	CbGbCtD
Tamsulosin—CYP3A4—Busulfan—hematologic cancer	0.0104	0.04	CbGbCtD
Tamsulosin—CYP3A4—Lomustine—hematologic cancer	0.0104	0.04	CbGbCtD
Tamsulosin—CYP3A4—Thiotepa—hematologic cancer	0.00929	0.0357	CbGbCtD
Tamsulosin—CYP2D6—Imatinib—hematologic cancer	0.00791	0.0304	CbGbCtD
Tamsulosin—CYP3A4—Methoxsalen—hematologic cancer	0.00722	0.0278	CbGbCtD
Tamsulosin—CYP2D6—Nilotinib—hematologic cancer	0.00719	0.0276	CbGbCtD
Tamsulosin—CYP2D6—Vinorelbine—hematologic cancer	0.00713	0.0274	CbGbCtD
Tamsulosin—CYP3A4—Bortezomib—hematologic cancer	0.00687	0.0264	CbGbCtD
Tamsulosin—CYP3A4—Daunorubicin—hematologic cancer	0.00657	0.0253	CbGbCtD
Tamsulosin—CYP3A4—Cytarabine—hematologic cancer	0.0058	0.0223	CbGbCtD
Tamsulosin—CYP3A4—Teniposide—hematologic cancer	0.00571	0.0219	CbGbCtD
Tamsulosin—CYP3A4—Ifosfamide—hematologic cancer	0.00527	0.0203	CbGbCtD
Tamsulosin—CYP3A4—Imatinib—hematologic cancer	0.00503	0.0193	CbGbCtD
Tamsulosin—CYP3A4—Ruxolitinib—hematologic cancer	0.00474	0.0182	CbGbCtD
Tamsulosin—CYP3A4—Nilotinib—hematologic cancer	0.00457	0.0176	CbGbCtD
Tamsulosin—CYP3A4—Vinorelbine—hematologic cancer	0.00453	0.0174	CbGbCtD
Tamsulosin—CYP2D6—Vinblastine—hematologic cancer	0.0044	0.0169	CbGbCtD
Tamsulosin—CYP3A4—Triamcinolone—hematologic cancer	0.00415	0.0159	CbGbCtD
Tamsulosin—CYP3A4—Dasatinib—hematologic cancer	0.00404	0.0155	CbGbCtD
Tamsulosin—CYP3A4—Mitoxantrone—hematologic cancer	0.00399	0.0153	CbGbCtD
Tamsulosin—CYP3A4—Betamethasone—hematologic cancer	0.00356	0.0137	CbGbCtD
Tamsulosin—CYP3A4—Prednisolone—hematologic cancer	0.00351	0.0135	CbGbCtD
Tamsulosin—CYP3A4—Prednisone—hematologic cancer	0.00332	0.0127	CbGbCtD
Tamsulosin—CYP2D6—Dexamethasone—hematologic cancer	0.00326	0.0125	CbGbCtD
Tamsulosin—CYP3A4—Irinotecan—hematologic cancer	0.00314	0.0121	CbGbCtD
Tamsulosin—CYP3A4—Vinblastine—hematologic cancer	0.00279	0.0107	CbGbCtD
Tamsulosin—CYP3A4—Vincristine—hematologic cancer	0.00275	0.0106	CbGbCtD
Tamsulosin—CYP2D6—Doxorubicin—hematologic cancer	0.0027	0.0104	CbGbCtD
Tamsulosin—CYP3A4—Etoposide—hematologic cancer	0.00252	0.00968	CbGbCtD
Tamsulosin—CYP3A4—Dexamethasone—hematologic cancer	0.00207	0.00796	CbGbCtD
Tamsulosin—CYP3A4—Doxorubicin—hematologic cancer	0.00172	0.0066	CbGbCtD
Tamsulosin—Bumetanide—CA9—hematologic cancer	0.000675	0.422	CrCbGaD
Tamsulosin—Silodosin—ABCB1—hematologic cancer	0.000421	0.263	CrCbGaD
Tamsulosin—Carvedilol—VEGFA—hematologic cancer	0.000403	0.251	CrCbGaD
Tamsulosin—ORM1—hematopoietic system—hematologic cancer	0.000326	0.0818	CbGeAlD
Tamsulosin—HTR1A—hematopoietic system—hematologic cancer	0.000246	0.0619	CbGeAlD
Tamsulosin—HTR7—hematopoietic system—hematologic cancer	0.000235	0.0591	CbGeAlD
Tamsulosin—ADRA1A—hematopoietic system—hematologic cancer	0.000227	0.057	CbGeAlD
Tamsulosin—ORM1—blood—hematologic cancer	0.000216	0.0542	CbGeAlD
Tamsulosin—ORM1—bone marrow—hematologic cancer	0.000209	0.0524	CbGeAlD
Tamsulosin—ORM1—lung—hematologic cancer	0.000189	0.0475	CbGeAlD
Tamsulosin—HTR7—gonad—hematologic cancer	0.000179	0.0449	CbGeAlD
Tamsulosin—ADRA2A—hematopoietic system—hematologic cancer	0.000173	0.0434	CbGeAlD
Tamsulosin—HTR7—blood—hematologic cancer	0.000156	0.0392	CbGeAlD
Tamsulosin—ADRA1A—blood—hematologic cancer	0.00015	0.0378	CbGeAlD
Tamsulosin—HTR7—lung—hematologic cancer	0.000137	0.0343	CbGeAlD
Tamsulosin—CYP3A4—hematopoietic system—hematologic cancer	0.000136	0.0341	CbGeAlD
Tamsulosin—CYP2D6—hematopoietic system—hematologic cancer	0.000134	0.0336	CbGeAlD
Tamsulosin—ADRA2A—gonad—hematologic cancer	0.000131	0.033	CbGeAlD
Tamsulosin—ORM1—lymph node—hematologic cancer	0.000129	0.0325	CbGeAlD
Tamsulosin—DRD2—lung—hematologic cancer	0.000129	0.0325	CbGeAlD
Tamsulosin—HTR7—testis—hematologic cancer	0.000129	0.0324	CbGeAlD
Tamsulosin—DRD2—testis—hematologic cancer	0.000122	0.0306	CbGeAlD
Tamsulosin—ADRA2A—blood—hematologic cancer	0.000114	0.0287	CbGeAlD
Tamsulosin—Carvedilol—ABCB1—hematologic cancer	0.000103	0.0645	CrCbGaD
Tamsulosin—ADRA2A—lung—hematologic cancer	0.0001	0.0252	CbGeAlD
Tamsulosin—ADRA2A—testis—hematologic cancer	9.46e-05	0.0238	CbGeAlD
Tamsulosin—CYP3A4—blood—hematologic cancer	9.01e-05	0.0226	CbGeAlD
Tamsulosin—CYP2D6—blood—hematologic cancer	8.86e-05	0.0222	CbGeAlD
Tamsulosin—CYP2D6—testis—hematologic cancer	7.33e-05	0.0184	CbGeAlD
Tamsulosin—ADRA2A—lymph node—hematologic cancer	6.86e-05	0.0172	CbGeAlD
Tamsulosin—Headache—Gemcitabine—hematologic cancer	3.03e-05	0.000179	CcSEcCtD
Tamsulosin—Nausea—Vincristine—hematologic cancer	3.03e-05	0.000179	CcSEcCtD
Tamsulosin—Cardiac disorder—Epirubicin—hematologic cancer	3.02e-05	0.000179	CcSEcCtD
Tamsulosin—Rhinitis—Doxorubicin—hematologic cancer	3.02e-05	0.000179	CcSEcCtD
Tamsulosin—Hypersensitivity—Prednisolone—hematologic cancer	3e-05	0.000178	CcSEcCtD
Tamsulosin—Pharyngitis—Doxorubicin—hematologic cancer	2.99e-05	0.000177	CcSEcCtD
Tamsulosin—Dyspepsia—Betamethasone—hematologic cancer	2.99e-05	0.000177	CcSEcCtD
Tamsulosin—Dyspepsia—Dexamethasone—hematologic cancer	2.99e-05	0.000177	CcSEcCtD
Tamsulosin—Urticaria—Triamcinolone—hematologic cancer	2.98e-05	0.000176	CcSEcCtD
Tamsulosin—Oedema peripheral—Doxorubicin—hematologic cancer	2.97e-05	0.000176	CcSEcCtD
Tamsulosin—Asthenia—Etoposide—hematologic cancer	2.96e-05	0.000175	CcSEcCtD
Tamsulosin—Connective tissue disorder—Doxorubicin—hematologic cancer	2.96e-05	0.000175	CcSEcCtD
Tamsulosin—Body temperature increased—Triamcinolone—hematologic cancer	2.96e-05	0.000175	CcSEcCtD
Tamsulosin—Angiopathy—Epirubicin—hematologic cancer	2.96e-05	0.000175	CcSEcCtD
Tamsulosin—Nausea—Mitoxantrone—hematologic cancer	2.95e-05	0.000175	CcSEcCtD
Tamsulosin—Nausea—Irinotecan—hematologic cancer	2.95e-05	0.000175	CcSEcCtD
Tamsulosin—Infection—Prednisone—hematologic cancer	2.94e-05	0.000174	CcSEcCtD
Tamsulosin—Mediastinal disorder—Epirubicin—hematologic cancer	2.94e-05	0.000174	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.93e-05	0.000174	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.93e-05	0.000174	CcSEcCtD
Tamsulosin—Back pain—Methotrexate—hematologic cancer	2.93e-05	0.000173	CcSEcCtD
Tamsulosin—Fatigue—Dexamethasone—hematologic cancer	2.93e-05	0.000173	CcSEcCtD
Tamsulosin—Fatigue—Betamethasone—hematologic cancer	2.93e-05	0.000173	CcSEcCtD
Tamsulosin—Chills—Epirubicin—hematologic cancer	2.92e-05	0.000173	CcSEcCtD
Tamsulosin—Pruritus—Etoposide—hematologic cancer	2.92e-05	0.000173	CcSEcCtD
Tamsulosin—Shock—Prednisone—hematologic cancer	2.91e-05	0.000172	CcSEcCtD
Tamsulosin—Arrhythmia—Epirubicin—hematologic cancer	2.91e-05	0.000172	CcSEcCtD
Tamsulosin—Pain—Dexamethasone—hematologic cancer	2.91e-05	0.000172	CcSEcCtD
Tamsulosin—Pain—Betamethasone—hematologic cancer	2.91e-05	0.000172	CcSEcCtD
Tamsulosin—Visual impairment—Doxorubicin—hematologic cancer	2.9e-05	0.000172	CcSEcCtD
Tamsulosin—Nervous system disorder—Prednisone—hematologic cancer	2.9e-05	0.000172	CcSEcCtD
Tamsulosin—Tachycardia—Prednisone—hematologic cancer	2.89e-05	0.000171	CcSEcCtD
Tamsulosin—Skin disorder—Prednisone—hematologic cancer	2.87e-05	0.00017	CcSEcCtD
Tamsulosin—Nausea—Gemcitabine—hematologic cancer	2.87e-05	0.00017	CcSEcCtD
Tamsulosin—Vomiting—Cisplatin—hematologic cancer	2.87e-05	0.00017	CcSEcCtD
Tamsulosin—Hyperhidrosis—Prednisone—hematologic cancer	2.86e-05	0.000169	CcSEcCtD
Tamsulosin—Vision blurred—Methotrexate—hematologic cancer	2.86e-05	0.000169	CcSEcCtD
Tamsulosin—Erythema multiforme—Doxorubicin—hematologic cancer	2.85e-05	0.000169	CcSEcCtD
Tamsulosin—Rash—Cisplatin—hematologic cancer	2.84e-05	0.000168	CcSEcCtD
Tamsulosin—Dermatitis—Cisplatin—hematologic cancer	2.84e-05	0.000168	CcSEcCtD
Tamsulosin—Malnutrition—Epirubicin—hematologic cancer	2.84e-05	0.000168	CcSEcCtD
Tamsulosin—Diarrhoea—Etoposide—hematologic cancer	2.83e-05	0.000167	CcSEcCtD
Tamsulosin—Ill-defined disorder—Methotrexate—hematologic cancer	2.81e-05	0.000166	CcSEcCtD
Tamsulosin—Feeling abnormal—Betamethasone—hematologic cancer	2.8e-05	0.000166	CcSEcCtD
Tamsulosin—Feeling abnormal—Dexamethasone—hematologic cancer	2.8e-05	0.000166	CcSEcCtD
Tamsulosin—Cardiac disorder—Doxorubicin—hematologic cancer	2.8e-05	0.000166	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.78e-05	0.000164	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Betamethasone—hematologic cancer	2.78e-05	0.000164	CcSEcCtD
Tamsulosin—Hypersensitivity—Triamcinolone—hematologic cancer	2.76e-05	0.000163	CcSEcCtD
Tamsulosin—Back pain—Epirubicin—hematologic cancer	2.74e-05	0.000162	CcSEcCtD
Tamsulosin—Angiopathy—Doxorubicin—hematologic cancer	2.73e-05	0.000162	CcSEcCtD
Tamsulosin—Malaise—Methotrexate—hematologic cancer	2.73e-05	0.000162	CcSEcCtD
Tamsulosin—Dizziness—Etoposide—hematologic cancer	2.73e-05	0.000162	CcSEcCtD
Tamsulosin—Vertigo—Methotrexate—hematologic cancer	2.72e-05	0.000161	CcSEcCtD
Tamsulosin—Mediastinal disorder—Doxorubicin—hematologic cancer	2.72e-05	0.000161	CcSEcCtD
Tamsulosin—Chills—Doxorubicin—hematologic cancer	2.7e-05	0.00016	CcSEcCtD
Tamsulosin—Urticaria—Dexamethasone—hematologic cancer	2.7e-05	0.00016	CcSEcCtD
Tamsulosin—Urticaria—Betamethasone—hematologic cancer	2.7e-05	0.00016	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.7e-05	0.00016	CcSEcCtD
Tamsulosin—Dizziness—Prednisolone—hematologic cancer	2.69e-05	0.000159	CcSEcCtD
Tamsulosin—Arrhythmia—Doxorubicin—hematologic cancer	2.69e-05	0.000159	CcSEcCtD
Tamsulosin—Asthenia—Triamcinolone—hematologic cancer	2.69e-05	0.000159	CcSEcCtD
Tamsulosin—Body temperature increased—Dexamethasone—hematologic cancer	2.69e-05	0.000159	CcSEcCtD
Tamsulosin—Abdominal pain—Betamethasone—hematologic cancer	2.69e-05	0.000159	CcSEcCtD
Tamsulosin—Body temperature increased—Betamethasone—hematologic cancer	2.69e-05	0.000159	CcSEcCtD
Tamsulosin—Abdominal pain—Dexamethasone—hematologic cancer	2.69e-05	0.000159	CcSEcCtD
Tamsulosin—Nausea—Cisplatin—hematologic cancer	2.68e-05	0.000158	CcSEcCtD
Tamsulosin—Insomnia—Prednisone—hematologic cancer	2.68e-05	0.000158	CcSEcCtD
Tamsulosin—Vision blurred—Epirubicin—hematologic cancer	2.67e-05	0.000158	CcSEcCtD
Tamsulosin—Paraesthesia—Prednisone—hematologic cancer	2.66e-05	0.000157	CcSEcCtD
Tamsulosin—Pruritus—Triamcinolone—hematologic cancer	2.65e-05	0.000157	CcSEcCtD
Tamsulosin—Cough—Methotrexate—hematologic cancer	2.64e-05	0.000157	CcSEcCtD
Tamsulosin—Ill-defined disorder—Epirubicin—hematologic cancer	2.63e-05	0.000156	CcSEcCtD
Tamsulosin—Vomiting—Etoposide—hematologic cancer	2.63e-05	0.000155	CcSEcCtD
Tamsulosin—Malnutrition—Doxorubicin—hematologic cancer	2.62e-05	0.000155	CcSEcCtD
Tamsulosin—Dyspepsia—Prednisone—hematologic cancer	2.61e-05	0.000154	CcSEcCtD
Tamsulosin—Rash—Etoposide—hematologic cancer	2.6e-05	0.000154	CcSEcCtD
Tamsulosin—Dermatitis—Etoposide—hematologic cancer	2.6e-05	0.000154	CcSEcCtD
Tamsulosin—Headache—Etoposide—hematologic cancer	2.59e-05	0.000153	CcSEcCtD
Tamsulosin—Chest pain—Methotrexate—hematologic cancer	2.58e-05	0.000153	CcSEcCtD
Tamsulosin—Myalgia—Methotrexate—hematologic cancer	2.58e-05	0.000153	CcSEcCtD
Tamsulosin—Arthralgia—Methotrexate—hematologic cancer	2.58e-05	0.000153	CcSEcCtD
Tamsulosin—Rash—Prednisolone—hematologic cancer	2.57e-05	0.000152	CcSEcCtD
Tamsulosin—Dermatitis—Prednisolone—hematologic cancer	2.57e-05	0.000152	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.56e-05	0.000152	CcSEcCtD
Tamsulosin—Malaise—Epirubicin—hematologic cancer	2.56e-05	0.000151	CcSEcCtD
Tamsulosin—Fatigue—Prednisone—hematologic cancer	2.55e-05	0.000151	CcSEcCtD
Tamsulosin—Headache—Prednisolone—hematologic cancer	2.55e-05	0.000151	CcSEcCtD
Tamsulosin—Discomfort—Methotrexate—hematologic cancer	2.55e-05	0.000151	CcSEcCtD
Tamsulosin—Vertigo—Epirubicin—hematologic cancer	2.55e-05	0.000151	CcSEcCtD
Tamsulosin—Syncope—Epirubicin—hematologic cancer	2.54e-05	0.000151	CcSEcCtD
Tamsulosin—Back pain—Doxorubicin—hematologic cancer	2.54e-05	0.00015	CcSEcCtD
Tamsulosin—Constipation—Prednisone—hematologic cancer	2.53e-05	0.00015	CcSEcCtD
Tamsulosin—Palpitations—Epirubicin—hematologic cancer	2.51e-05	0.000148	CcSEcCtD
Tamsulosin—Loss of consciousness—Epirubicin—hematologic cancer	2.49e-05	0.000148	CcSEcCtD
Tamsulosin—Dizziness—Triamcinolone—hematologic cancer	2.48e-05	0.000147	CcSEcCtD
Tamsulosin—Cough—Epirubicin—hematologic cancer	2.47e-05	0.000146	CcSEcCtD
Tamsulosin—Vision blurred—Doxorubicin—hematologic cancer	2.47e-05	0.000146	CcSEcCtD
Tamsulosin—Infection—Methotrexate—hematologic cancer	2.46e-05	0.000145	CcSEcCtD
Tamsulosin—Nausea—Etoposide—hematologic cancer	2.45e-05	0.000145	CcSEcCtD
Tamsulosin—Hypertension—Epirubicin—hematologic cancer	2.45e-05	0.000145	CcSEcCtD
Tamsulosin—Feeling abnormal—Prednisone—hematologic cancer	2.44e-05	0.000144	CcSEcCtD
Tamsulosin—Asthenia—Dexamethasone—hematologic cancer	2.44e-05	0.000144	CcSEcCtD
Tamsulosin—Asthenia—Betamethasone—hematologic cancer	2.44e-05	0.000144	CcSEcCtD
Tamsulosin—Ill-defined disorder—Doxorubicin—hematologic cancer	2.43e-05	0.000144	CcSEcCtD
Tamsulosin—Nervous system disorder—Methotrexate—hematologic cancer	2.43e-05	0.000144	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Prednisone—hematologic cancer	2.42e-05	0.000143	CcSEcCtD
Tamsulosin—Nausea—Prednisolone—hematologic cancer	2.42e-05	0.000143	CcSEcCtD
Tamsulosin—Chest pain—Epirubicin—hematologic cancer	2.41e-05	0.000143	CcSEcCtD
Tamsulosin—Myalgia—Epirubicin—hematologic cancer	2.41e-05	0.000143	CcSEcCtD
Tamsulosin—Arthralgia—Epirubicin—hematologic cancer	2.41e-05	0.000143	CcSEcCtD
Tamsulosin—Pruritus—Betamethasone—hematologic cancer	2.4e-05	0.000142	CcSEcCtD
Tamsulosin—Pruritus—Dexamethasone—hematologic cancer	2.4e-05	0.000142	CcSEcCtD
Tamsulosin—Skin disorder—Methotrexate—hematologic cancer	2.4e-05	0.000142	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.4e-05	0.000142	CcSEcCtD
Tamsulosin—Hyperhidrosis—Methotrexate—hematologic cancer	2.39e-05	0.000142	CcSEcCtD
Tamsulosin—Discomfort—Epirubicin—hematologic cancer	2.39e-05	0.000141	CcSEcCtD
Tamsulosin—Vomiting—Triamcinolone—hematologic cancer	2.38e-05	0.000141	CcSEcCtD
Tamsulosin—Malaise—Doxorubicin—hematologic cancer	2.37e-05	0.00014	CcSEcCtD
Tamsulosin—Rash—Triamcinolone—hematologic cancer	2.36e-05	0.00014	CcSEcCtD
Tamsulosin—Dermatitis—Triamcinolone—hematologic cancer	2.36e-05	0.00014	CcSEcCtD
Tamsulosin—Vertigo—Doxorubicin—hematologic cancer	2.36e-05	0.00014	CcSEcCtD
Tamsulosin—Syncope—Doxorubicin—hematologic cancer	2.35e-05	0.000139	CcSEcCtD
Tamsulosin—Urticaria—Prednisone—hematologic cancer	2.35e-05	0.000139	CcSEcCtD
Tamsulosin—Headache—Triamcinolone—hematologic cancer	2.35e-05	0.000139	CcSEcCtD
Tamsulosin—Body temperature increased—Prednisone—hematologic cancer	2.34e-05	0.000138	CcSEcCtD
Tamsulosin—Abdominal pain—Prednisone—hematologic cancer	2.34e-05	0.000138	CcSEcCtD
Tamsulosin—Diarrhoea—Dexamethasone—hematologic cancer	2.33e-05	0.000138	CcSEcCtD
Tamsulosin—Diarrhoea—Betamethasone—hematologic cancer	2.33e-05	0.000138	CcSEcCtD
Tamsulosin—Palpitations—Doxorubicin—hematologic cancer	2.32e-05	0.000137	CcSEcCtD
Tamsulosin—Hypotension—Methotrexate—hematologic cancer	2.31e-05	0.000137	CcSEcCtD
Tamsulosin—Loss of consciousness—Doxorubicin—hematologic cancer	2.31e-05	0.000137	CcSEcCtD
Tamsulosin—Infection—Epirubicin—hematologic cancer	2.3e-05	0.000136	CcSEcCtD
Tamsulosin—Cough—Doxorubicin—hematologic cancer	2.29e-05	0.000136	CcSEcCtD
Tamsulosin—Shock—Epirubicin—hematologic cancer	2.28e-05	0.000135	CcSEcCtD
Tamsulosin—Nervous system disorder—Epirubicin—hematologic cancer	2.27e-05	0.000134	CcSEcCtD
Tamsulosin—Hypertension—Doxorubicin—hematologic cancer	2.27e-05	0.000134	CcSEcCtD
Tamsulosin—Tachycardia—Epirubicin—hematologic cancer	2.26e-05	0.000134	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.25e-05	0.000133	CcSEcCtD
Tamsulosin—Skin disorder—Epirubicin—hematologic cancer	2.25e-05	0.000133	CcSEcCtD
Tamsulosin—Dizziness—Dexamethasone—hematologic cancer	2.25e-05	0.000133	CcSEcCtD
Tamsulosin—Dizziness—Betamethasone—hematologic cancer	2.25e-05	0.000133	CcSEcCtD
Tamsulosin—Hyperhidrosis—Epirubicin—hematologic cancer	2.24e-05	0.000132	CcSEcCtD
Tamsulosin—Insomnia—Methotrexate—hematologic cancer	2.24e-05	0.000132	CcSEcCtD
Tamsulosin—Arthralgia—Doxorubicin—hematologic cancer	2.23e-05	0.000132	CcSEcCtD
Tamsulosin—Chest pain—Doxorubicin—hematologic cancer	2.23e-05	0.000132	CcSEcCtD
Tamsulosin—Myalgia—Doxorubicin—hematologic cancer	2.23e-05	0.000132	CcSEcCtD
Tamsulosin—Nausea—Triamcinolone—hematologic cancer	2.22e-05	0.000132	CcSEcCtD
Tamsulosin—Paraesthesia—Methotrexate—hematologic cancer	2.22e-05	0.000131	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.22e-05	0.000131	CcSEcCtD
Tamsulosin—Discomfort—Doxorubicin—hematologic cancer	2.21e-05	0.000131	CcSEcCtD
Tamsulosin—Dyspnoea—Methotrexate—hematologic cancer	2.21e-05	0.000131	CcSEcCtD
Tamsulosin—Somnolence—Methotrexate—hematologic cancer	2.2e-05	0.00013	CcSEcCtD
Tamsulosin—Hypersensitivity—Prednisone—hematologic cancer	2.18e-05	0.000129	CcSEcCtD
Tamsulosin—Dyspepsia—Methotrexate—hematologic cancer	2.18e-05	0.000129	CcSEcCtD
Tamsulosin—Hypotension—Epirubicin—hematologic cancer	2.16e-05	0.000128	CcSEcCtD
Tamsulosin—Vomiting—Dexamethasone—hematologic cancer	2.16e-05	0.000128	CcSEcCtD
Tamsulosin—Vomiting—Betamethasone—hematologic cancer	2.16e-05	0.000128	CcSEcCtD
Tamsulosin—Rash—Betamethasone—hematologic cancer	2.14e-05	0.000127	CcSEcCtD
Tamsulosin—Rash—Dexamethasone—hematologic cancer	2.14e-05	0.000127	CcSEcCtD
Tamsulosin—Dermatitis—Dexamethasone—hematologic cancer	2.14e-05	0.000127	CcSEcCtD
Tamsulosin—Dermatitis—Betamethasone—hematologic cancer	2.14e-05	0.000127	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.14e-05	0.000126	CcSEcCtD
Tamsulosin—Fatigue—Methotrexate—hematologic cancer	2.13e-05	0.000126	CcSEcCtD
Tamsulosin—Headache—Betamethasone—hematologic cancer	2.13e-05	0.000126	CcSEcCtD
Tamsulosin—Headache—Dexamethasone—hematologic cancer	2.13e-05	0.000126	CcSEcCtD
Tamsulosin—Infection—Doxorubicin—hematologic cancer	2.13e-05	0.000126	CcSEcCtD
Tamsulosin—Asthenia—Prednisone—hematologic cancer	2.12e-05	0.000126	CcSEcCtD
Tamsulosin—Pain—Methotrexate—hematologic cancer	2.12e-05	0.000125	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.11e-05	0.000125	CcSEcCtD
Tamsulosin—Shock—Doxorubicin—hematologic cancer	2.11e-05	0.000125	CcSEcCtD
Tamsulosin—Nervous system disorder—Doxorubicin—hematologic cancer	2.1e-05	0.000124	CcSEcCtD
Tamsulosin—Pruritus—Prednisone—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Tamsulosin—Insomnia—Epirubicin—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Tamsulosin—Tachycardia—Doxorubicin—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Tamsulosin—Skin disorder—Doxorubicin—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Tamsulosin—Paraesthesia—Epirubicin—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Tamsulosin—Hyperhidrosis—Doxorubicin—hematologic cancer	2.07e-05	0.000123	CcSEcCtD
Tamsulosin—Dyspnoea—Epirubicin—hematologic cancer	2.06e-05	0.000122	CcSEcCtD
Tamsulosin—Somnolence—Epirubicin—hematologic cancer	2.06e-05	0.000122	CcSEcCtD
Tamsulosin—Feeling abnormal—Methotrexate—hematologic cancer	2.04e-05	0.000121	CcSEcCtD
Tamsulosin—Dyspepsia—Epirubicin—hematologic cancer	2.04e-05	0.000121	CcSEcCtD
Tamsulosin—Diarrhoea—Prednisone—hematologic cancer	2.02e-05	0.00012	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Methotrexate—hematologic cancer	2.02e-05	0.00012	CcSEcCtD
Tamsulosin—Nausea—Dexamethasone—hematologic cancer	2.02e-05	0.000119	CcSEcCtD
Tamsulosin—Nausea—Betamethasone—hematologic cancer	2.02e-05	0.000119	CcSEcCtD
Tamsulosin—Hypotension—Doxorubicin—hematologic cancer	2e-05	0.000118	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Epirubicin—hematologic cancer	2e-05	0.000118	CcSEcCtD
Tamsulosin—Fatigue—Epirubicin—hematologic cancer	2e-05	0.000118	CcSEcCtD
Tamsulosin—Pain—Epirubicin—hematologic cancer	1.98e-05	0.000117	CcSEcCtD
Tamsulosin—Constipation—Epirubicin—hematologic cancer	1.98e-05	0.000117	CcSEcCtD
Tamsulosin—Urticaria—Methotrexate—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Tamsulosin—Dizziness—Prednisone—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Tamsulosin—Body temperature increased—Methotrexate—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Tamsulosin—Abdominal pain—Methotrexate—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.95e-05	0.000115	CcSEcCtD
Tamsulosin—Insomnia—Doxorubicin—hematologic cancer	1.94e-05	0.000115	CcSEcCtD
Tamsulosin—Paraesthesia—Doxorubicin—hematologic cancer	1.92e-05	0.000114	CcSEcCtD
Tamsulosin—Dyspnoea—Doxorubicin—hematologic cancer	1.91e-05	0.000113	CcSEcCtD
Tamsulosin—Feeling abnormal—Epirubicin—hematologic cancer	1.91e-05	0.000113	CcSEcCtD
Tamsulosin—Somnolence—Doxorubicin—hematologic cancer	1.9e-05	0.000113	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.89e-05	0.000112	CcSEcCtD
Tamsulosin—Dyspepsia—Doxorubicin—hematologic cancer	1.89e-05	0.000112	CcSEcCtD
Tamsulosin—Vomiting—Prednisone—hematologic cancer	1.88e-05	0.000111	CcSEcCtD
Tamsulosin—Rash—Prednisone—hematologic cancer	1.87e-05	0.00011	CcSEcCtD
Tamsulosin—Dermatitis—Prednisone—hematologic cancer	1.86e-05	0.00011	CcSEcCtD
Tamsulosin—Headache—Prednisone—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.85e-05	0.000109	CcSEcCtD
Tamsulosin—Fatigue—Doxorubicin—hematologic cancer	1.85e-05	0.000109	CcSEcCtD
Tamsulosin—Urticaria—Epirubicin—hematologic cancer	1.84e-05	0.000109	CcSEcCtD
Tamsulosin—Pain—Doxorubicin—hematologic cancer	1.83e-05	0.000108	CcSEcCtD
Tamsulosin—Constipation—Doxorubicin—hematologic cancer	1.83e-05	0.000108	CcSEcCtD
Tamsulosin—Body temperature increased—Epirubicin—hematologic cancer	1.83e-05	0.000108	CcSEcCtD
Tamsulosin—Abdominal pain—Epirubicin—hematologic cancer	1.83e-05	0.000108	CcSEcCtD
Tamsulosin—Hypersensitivity—Methotrexate—hematologic cancer	1.82e-05	0.000108	CcSEcCtD
Tamsulosin—Asthenia—Methotrexate—hematologic cancer	1.77e-05	0.000105	CcSEcCtD
Tamsulosin—Feeling abnormal—Doxorubicin—hematologic cancer	1.76e-05	0.000104	CcSEcCtD
Tamsulosin—Nausea—Prednisone—hematologic cancer	1.76e-05	0.000104	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Tamsulosin—Pruritus—Methotrexate—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Tamsulosin—Hypersensitivity—Epirubicin—hematologic cancer	1.71e-05	0.000101	CcSEcCtD
Tamsulosin—Urticaria—Doxorubicin—hematologic cancer	1.7e-05	0.000101	CcSEcCtD
Tamsulosin—Abdominal pain—Doxorubicin—hematologic cancer	1.69e-05	0.0001	CcSEcCtD
Tamsulosin—Body temperature increased—Doxorubicin—hematologic cancer	1.69e-05	0.0001	CcSEcCtD
Tamsulosin—Diarrhoea—Methotrexate—hematologic cancer	1.69e-05	0.0001	CcSEcCtD
Tamsulosin—Asthenia—Epirubicin—hematologic cancer	1.66e-05	9.83e-05	CcSEcCtD
Tamsulosin—Pruritus—Epirubicin—hematologic cancer	1.64e-05	9.69e-05	CcSEcCtD
Tamsulosin—Dizziness—Methotrexate—hematologic cancer	1.64e-05	9.68e-05	CcSEcCtD
Tamsulosin—Diarrhoea—Epirubicin—hematologic cancer	1.58e-05	9.37e-05	CcSEcCtD
Tamsulosin—Hypersensitivity—Doxorubicin—hematologic cancer	1.58e-05	9.34e-05	CcSEcCtD
Tamsulosin—Vomiting—Methotrexate—hematologic cancer	1.57e-05	9.31e-05	CcSEcCtD
Tamsulosin—Rash—Methotrexate—hematologic cancer	1.56e-05	9.23e-05	CcSEcCtD
Tamsulosin—Dermatitis—Methotrexate—hematologic cancer	1.56e-05	9.22e-05	CcSEcCtD
Tamsulosin—Headache—Methotrexate—hematologic cancer	1.55e-05	9.17e-05	CcSEcCtD
Tamsulosin—Asthenia—Doxorubicin—hematologic cancer	1.54e-05	9.09e-05	CcSEcCtD
Tamsulosin—Dizziness—Epirubicin—hematologic cancer	1.53e-05	9.06e-05	CcSEcCtD
Tamsulosin—Pruritus—Doxorubicin—hematologic cancer	1.52e-05	8.97e-05	CcSEcCtD
Tamsulosin—Vomiting—Epirubicin—hematologic cancer	1.47e-05	8.71e-05	CcSEcCtD
Tamsulosin—Nausea—Methotrexate—hematologic cancer	1.47e-05	8.7e-05	CcSEcCtD
Tamsulosin—Diarrhoea—Doxorubicin—hematologic cancer	1.47e-05	8.67e-05	CcSEcCtD
Tamsulosin—Rash—Epirubicin—hematologic cancer	1.46e-05	8.64e-05	CcSEcCtD
Tamsulosin—Dermatitis—Epirubicin—hematologic cancer	1.46e-05	8.63e-05	CcSEcCtD
Tamsulosin—Headache—Epirubicin—hematologic cancer	1.45e-05	8.58e-05	CcSEcCtD
Tamsulosin—Dizziness—Doxorubicin—hematologic cancer	1.42e-05	8.38e-05	CcSEcCtD
Tamsulosin—Nausea—Epirubicin—hematologic cancer	1.37e-05	8.14e-05	CcSEcCtD
Tamsulosin—Vomiting—Doxorubicin—hematologic cancer	1.36e-05	8.06e-05	CcSEcCtD
Tamsulosin—Rash—Doxorubicin—hematologic cancer	1.35e-05	7.99e-05	CcSEcCtD
Tamsulosin—Dermatitis—Doxorubicin—hematologic cancer	1.35e-05	7.98e-05	CcSEcCtD
Tamsulosin—Headache—Doxorubicin—hematologic cancer	1.34e-05	7.94e-05	CcSEcCtD
Tamsulosin—Nausea—Doxorubicin—hematologic cancer	1.27e-05	7.53e-05	CcSEcCtD
Tamsulosin—HTR7—Signaling Pathways—MAPK3—hematologic cancer	2.36e-06	4.87e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—CDKN1A—hematologic cancer	2.36e-06	4.86e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—CDKN1A—hematologic cancer	2.36e-06	4.86e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—PTEN—hematologic cancer	2.35e-06	4.85e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—PTEN—hematologic cancer	2.35e-06	4.85e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—KRAS—hematologic cancer	2.34e-06	4.82e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—PIK3CA—hematologic cancer	2.33e-06	4.81e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—MAPK3—hematologic cancer	2.33e-06	4.8e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MDM2—hematologic cancer	2.32e-06	4.79e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAP2K1—hematologic cancer	2.32e-06	4.78e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CREB1—hematologic cancer	2.32e-06	4.78e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CD—hematologic cancer	2.3e-06	4.75e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MAPK8—hematologic cancer	2.3e-06	4.74e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MAPK8—hematologic cancer	2.3e-06	4.74e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—MYC—hematologic cancer	2.3e-06	4.74e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—AKT1—hematologic cancer	2.29e-06	4.73e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—AKT1—hematologic cancer	2.29e-06	4.73e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TGFB1—hematologic cancer	2.29e-06	4.73e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—FGF2—hematologic cancer	2.29e-06	4.72e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—BRAF—hematologic cancer	2.29e-06	4.72e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	2.28e-06	4.7e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CCL2—hematologic cancer	2.27e-06	4.67e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	2.26e-06	4.67e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL6R—hematologic cancer	2.26e-06	4.66e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MTOR—hematologic cancer	2.26e-06	4.66e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CB—hematologic cancer	2.26e-06	4.66e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.26e-06	4.65e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	2.26e-06	4.65e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CREBBP—hematologic cancer	2.26e-06	4.65e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	2.25e-06	4.65e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—EP300—hematologic cancer	2.24e-06	4.62e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—EP300—hematologic cancer	2.24e-06	4.62e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CB—hematologic cancer	2.23e-06	4.6e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	2.23e-06	4.59e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	2.2e-06	4.55e-05	CbGpPWpGaD
Tamsulosin—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	2.2e-06	4.54e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—JAK2—hematologic cancer	2.19e-06	4.52e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CASP3—hematologic cancer	2.18e-06	4.5e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—SRC—hematologic cancer	2.18e-06	4.5e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—SRC—hematologic cancer	2.18e-06	4.5e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL2—hematologic cancer	2.18e-06	4.49e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NQO1—hematologic cancer	2.18e-06	4.49e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CD44—hematologic cancer	2.18e-06	4.49e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	2.17e-06	4.48e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—IL6—hematologic cancer	2.17e-06	4.47e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—HRAS—hematologic cancer	2.16e-06	4.45e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAP2K1—hematologic cancer	2.15e-06	4.44e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	2.15e-06	4.43e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MDM2—hematologic cancer	2.14e-06	4.41e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CD—hematologic cancer	2.14e-06	4.41e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—VEGFA—hematologic cancer	2.12e-06	4.38e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—VEGFA—hematologic cancer	2.12e-06	4.38e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—KRAS—hematologic cancer	2.12e-06	4.38e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CCND1—hematologic cancer	2.12e-06	4.38e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1B—hematologic cancer	2.12e-06	4.37e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—JUN—hematologic cancer	2.12e-06	4.37e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	2.12e-06	4.37e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	2.11e-06	4.36e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—STAT3—hematologic cancer	2.1e-06	4.34e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—STAT3—hematologic cancer	2.1e-06	4.34e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—NRAS—hematologic cancer	2.1e-06	4.33e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—NRAS—hematologic cancer	2.1e-06	4.33e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—GPCR downstream signaling—AKT1—hematologic cancer	2.1e-06	4.32e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—KRAS—hematologic cancer	2.09e-06	4.32e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MTOR—hematologic cancer	2.08e-06	4.29e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	2.08e-06	4.29e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CASP3—hematologic cancer	2.08e-06	4.28e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL2—hematologic cancer	2.07e-06	4.28e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	2.07e-06	4.27e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—IL6—hematologic cancer	2.06e-06	4.26e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	2.06e-06	4.25e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYCS—hematologic cancer	2.06e-06	4.25e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	2.05e-06	4.24e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PTEN—hematologic cancer	2.05e-06	4.23e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.05e-06	4.22e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—FGF2—hematologic cancer	2.05e-06	4.22e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CCND1—hematologic cancer	2.02e-06	4.17e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3R1—hematologic cancer	2.02e-06	4.16e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—JUN—hematologic cancer	2.02e-06	4.16e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MAPK3—hematologic cancer	2.01e-06	4.14e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MAPK3—hematologic cancer	2.01e-06	4.14e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	2.01e-06	4.14e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	2.01e-06	4.14e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	2.01e-06	4.13e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	2e-06	4.12e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—HRAS—hematologic cancer	1.99e-06	4.1e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—JAK2—hematologic cancer	1.96e-06	4.05e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1A—hematologic cancer	1.96e-06	4.03e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—EP300—hematologic cancer	1.95e-06	4.03e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MYC—hematologic cancer	1.95e-06	4.03e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MYC—hematologic cancer	1.95e-06	4.03e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	1.95e-06	4.03e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	1.95e-06	4.03e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—PIK3CA—hematologic cancer	1.95e-06	4.02e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TGFB1—hematologic cancer	1.95e-06	4.02e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TGFB1—hematologic cancer	1.95e-06	4.02e-05	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	1.93e-06	3.99e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PTEN—hematologic cancer	1.93e-06	3.97e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	1.92e-06	3.97e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	1.92e-06	3.95e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	1.92e-06	3.95e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CASP3—hematologic cancer	1.92e-06	3.95e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL2—hematologic cancer	1.91e-06	3.94e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	1.91e-06	3.94e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	1.9e-06	3.93e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—IL6—hematologic cancer	1.9e-06	3.92e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—SRC—hematologic cancer	1.9e-06	3.92e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.9e-06	3.91e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TP53—hematologic cancer	1.89e-06	3.89e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	1.88e-06	3.88e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.86e-06	3.84e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	1.86e-06	3.84e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	1.86e-06	3.84e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	1.86e-06	3.84e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—EP300—hematologic cancer	1.86e-06	3.84e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—JUN—hematologic cancer	1.86e-06	3.84e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	1.85e-06	3.82e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	1.85e-06	3.81e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL2—hematologic cancer	1.84e-06	3.8e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—EP300—hematologic cancer	1.84e-06	3.79e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	1.83e-06	3.78e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—STAT3—hematologic cancer	1.83e-06	3.78e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—NRAS—hematologic cancer	1.83e-06	3.77e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.82e-06	3.75e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—SRC—hematologic cancer	1.81e-06	3.73e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—KRAS—hematologic cancer	1.81e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—KRAS—hematologic cancer	1.81e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—HRAS—hematologic cancer	1.81e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.8e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.8e-06	3.71e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	1.8e-06	3.7e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—JUN—hematologic cancer	1.79e-06	3.7e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	1.78e-06	3.67e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	1.76e-06	3.64e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.76e-06	3.63e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.76e-06	3.62e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.76e-06	3.62e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	1.75e-06	3.61e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	1.75e-06	3.61e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	1.75e-06	3.6e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	1.74e-06	3.59e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	1.74e-06	3.58e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	1.73e-06	3.58e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	1.73e-06	3.57e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—IL6—hematologic cancer	1.73e-06	3.56e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.72e-06	3.55e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—EP300—hematologic cancer	1.72e-06	3.54e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	1.71e-06	3.54e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL2—hematologic cancer	1.71e-06	3.53e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	1.7e-06	3.51e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MYC—hematologic cancer	1.7e-06	3.51e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	1.7e-06	3.5e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	1.7e-06	3.5e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	1.69e-06	3.49e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.67e-06	3.44e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.67e-06	3.44e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.67e-06	3.44e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—SRC—hematologic cancer	1.67e-06	3.44e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	1.67e-06	3.44e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.67e-06	3.44e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.67e-06	3.43e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	1.66e-06	3.42e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	1.66e-06	3.42e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.65e-06	3.41e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—ALB—hematologic cancer	1.65e-06	3.39e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.63e-06	3.35e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MYC—hematologic cancer	1.62e-06	3.35e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	1.62e-06	3.34e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.61e-06	3.33e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.61e-06	3.32e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.61e-06	3.32e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.61e-06	3.32e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.61e-06	3.31e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TP53—hematologic cancer	1.61e-06	3.31e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TP53—hematologic cancer	1.61e-06	3.31e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—AKT1—hematologic cancer	1.59e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.58e-06	3.25e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.57e-06	3.25e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.57e-06	3.25e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.57e-06	3.24e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.57e-06	3.23e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.55e-06	3.2e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.55e-06	3.19e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.54e-06	3.17e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.54e-06	3.17e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—HRAS—hematologic cancer	1.54e-06	3.17e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	1.54e-06	3.17e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	1.5e-06	3.09e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MYC—hematologic cancer	1.5e-06	3.08e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.49e-06	3.08e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.49e-06	3.08e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.48e-06	3.05e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.48e-06	3.04e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—IL6—hematologic cancer	1.47e-06	3.03e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—IL6—hematologic cancer	1.47e-06	3.03e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.46e-06	3e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.45e-06	3e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.45e-06	2.98e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.44e-06	2.97e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.44e-06	2.97e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.44e-06	2.96e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.44e-06	2.96e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.4e-06	2.88e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.38e-06	2.85e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	1.38e-06	2.84e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.38e-06	2.84e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.36e-06	2.8e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—AKT1—hematologic cancer	1.36e-06	2.79e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	1.36e-06	2.79e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MYC—hematologic cancer	1.34e-06	2.76e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.34e-06	2.76e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	1.34e-06	2.75e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TP53—hematologic cancer	1.33e-06	2.75e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	1.33e-06	2.75e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.28e-06	2.64e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	1.27e-06	2.63e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.27e-06	2.62e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PTEN—hematologic cancer	1.26e-06	2.59e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.24e-06	2.56e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	1.24e-06	2.55e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TP53—hematologic cancer	1.23e-06	2.53e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	1.22e-06	2.52e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL6—hematologic cancer	1.22e-06	2.51e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—EP300—hematologic cancer	1.2e-06	2.47e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TP53—hematologic cancer	1.18e-06	2.44e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.18e-06	2.44e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.17e-06	2.42e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.15e-06	2.37e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	1.14e-06	2.34e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	1.13e-06	2.33e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	1.12e-06	2.32e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL6—hematologic cancer	1.12e-06	2.32e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—AKT1—hematologic cancer	1.11e-06	2.29e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TP53—hematologic cancer	1.1e-06	2.27e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.09e-06	2.25e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL6—hematologic cancer	1.08e-06	2.23e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ALB—hematologic cancer	1.08e-06	2.22e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	1.05e-06	2.17e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.04e-06	2.14e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.03e-06	2.12e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL6—hematologic cancer	1.01e-06	2.08e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	9.99e-07	2.06e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.5e-07	1.96e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	9.28e-07	1.91e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.86e-07	1.83e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PTEN—hematologic cancer	8.21e-07	1.69e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—EP300—hematologic cancer	7.83e-07	1.61e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—AKT1—hematologic cancer	7.24e-07	1.49e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.79e-07	1.19e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—AKT1—hematologic cancer	4.73e-07	9.75e-06	CbGpPWpGaD
